Innospec Inc. (NASDAQ:IOSP – Get Rating) Director Leslie J. Parrette purchased 450 shares of the company’s stock in a transaction on Friday, March 3rd. The stock was bought at an average cost of $111.35 per share, for a total transaction of $50,107.50. Following the acquisition, the director now directly owns 1,044 shares of the company’s stock, valued at approximately $116,249.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Innospec Trading Down 5.1 %
NASDAQ IOSP opened at $105.70 on Tuesday. The firm has a market capitalization of $2.62 billion, a P/E ratio of 19.87 and a beta of 1.17. The firm’s fifty day moving average price is $109.58 and its two-hundred day moving average price is $102.20. Innospec Inc. has a 1 year low of $83.13 and a 1 year high of $116.00.
Innospec (NASDAQ:IOSP – Get Rating) last posted its quarterly earnings data on Tuesday, February 21st. The specialty chemicals company reported $1.20 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.17). Innospec had a net margin of 6.77% and a return on equity of 14.14%. The firm had revenue of $510.70 million during the quarter, compared to the consensus estimate of $485.73 million. During the same period in the prior year, the company posted $1.30 earnings per share. The company’s revenue for the quarter was up 23.6% compared to the same quarter last year. On average, research analysts anticipate that Innospec Inc. will post 5.94 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the company. CWM LLC grew its position in Innospec by 49.2% during the 4th quarter. CWM LLC now owns 294 shares of the specialty chemicals company’s stock valued at $30,000 after purchasing an additional 97 shares during the last quarter. Pinebridge Investments L.P. purchased a new stake in Innospec in the 2nd quarter worth approximately $29,000. Parallel Advisors LLC purchased a new stake in Innospec during the 4th quarter valued at approximately $33,000. Captrust Financial Advisors grew its holdings in Innospec by 74.7% during the 1st quarter. Captrust Financial Advisors now owns 498 shares of the specialty chemicals company’s stock valued at $46,000 after buying an additional 213 shares in the last quarter. Finally, Quadrant Capital Group LLC boosted its position in shares of Innospec by 557.5% during the 3rd quarter. Quadrant Capital Group LLC now owns 526 shares of the specialty chemicals company’s stock valued at $45,000 after acquiring an additional 446 shares during the last quarter. 94.97% of the stock is owned by hedge funds and other institutional investors.
Innospec Company Profile
Innospec, Inc develops, manufactures, blends, markets and supplies fuel additives, oilfield chemicals, personal care, and other specialty chemicals. It operates through the following segments: Fuel Specialties, Performance Chemicals and Oilfield Services. The Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives to a range of fuels.
- Get a free copy of the StockNews.com research report on Innospec (IOSP)
- Go Where the Money Is. Here’s 3 Top Bank Dividend Stocks to Buy
- Another Catalyst For Mullen Automotive Stock
- Solar Tech-Services; Nextracker Should Be On Your Radar
- Is American Lithium a Safe Bet as Demand for Lithium Soars
- Highwoods Properties, High-quality Real Estate for a Discount
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.